NSCLC STAGE IIIB

Clinical trials for NSCLC STAGE IIIB explained in plain language.

Never miss a new study

Get alerted when new NSCLC STAGE IIIB trials appear

Sign up with your email to follow new studies for NSCLC STAGE IIIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Not yet finished but already full! 1 Completed 1 Terminated 1

Blood test may predict lung cancer drug success

Disease control Ongoing

This study looks at whether a blood test (liquid biopsy) can help doctors see how well the drug brigatinib is working in people with a certain type of advanced lung cancer (ALK-positive NSCLC). About 33 patients who have not had chemotherapy before will take brigatinib pills dail…

Matched conditions: NSCLC STAGE IIIB

Phase: PHASE2 • Sponsor: Fundación GECP • Aim: Disease control

Last updated Jun 27, 2026 09:02 UTC

NSCLC STAGE IIIB

Get alerted when new NSCLC STAGE IIIB trials appear

Blood test may predict lung cancer drug success